Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abhishek K Verma

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The Medical Journal of Australia|April 7, 2010
Dabigatran etexilate: a new thrombin inhibitorAbhishek K Verma
ANZ Journal of Surgery|January 19, 2010
New agents for orthopaedic thromboprophylaxis: caution essential, but time will tellAbhishek K Verma
ANZ Journal of Surgery|October 31, 2013
Millipede burn masquerading as trash foot in a paediatric patientAbhishek K Verma, Bernie Bourke
The Medical Journal of Australia|April 9, 2009
The direct factor Xa inhibitor rivaroxabanAbhishek K Verma, Timothy A Brighton
Frontiers in Microbiology|July 24, 2018
Chandipura Virus Induced Neuronal Apoptosis via Calcium Signaling Mediated Oxidative StressAbhishek K Verma, Sourish Ghosh, Anirban Basu
Iscience|December 6, 2022
mRNA vaccines elicit potent neutralization against multiple SARS-CoV-2 omicron subvariants and other variants of concernGang Wang, Juan Shi, Abhishek K Verma, et al.
Iscience|October 12, 2023
Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challengeXiaoqing Guan, Abhishek K Verma, Gang Wang, et al.
Cells|December 10, 2025
MERS-CoV RBD-mRNA Presents Better Immunogenicity and Protection than the Spike-mRNAQian Liu, Abhishek K Verma, Xiaoqing Guan, et al.
Vaccines|June 27, 2024
A Unique mRNA Vaccine Elicits Protective Efficacy against the SARS-CoV-2 Omicron Variant and SARS-CoVXiaoqing Guan, Abhishek K Verma, Gang Wang, et al.
ACS Applied Bio Materials|May 23, 2025
Modulation of Doxorubicin-Induced ROS Accumulation in Cardiomyocytes Using Ibuprofen-Conjugated Synthetic Lipids as CarriersSoumya Saroj, Akshaya Kana Veedu, Chandrasekhar Reddy U, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Medical Journal of Australia|April 7, 2010
Dabigatran etexilate: a new thrombin inhibitorAbhishek K Verma
ANZ Journal of Surgery|January 19, 2010
New agents for orthopaedic thromboprophylaxis: caution essential, but time will tellAbhishek K Verma
ANZ Journal of Surgery|October 31, 2013
Millipede burn masquerading as trash foot in a paediatric patientAbhishek K Verma, Bernie Bourke
The Medical Journal of Australia|April 9, 2009
The direct factor Xa inhibitor rivaroxabanAbhishek K Verma, Timothy A Brighton
Frontiers in Microbiology|July 24, 2018
Chandipura Virus Induced Neuronal Apoptosis via Calcium Signaling Mediated Oxidative StressAbhishek K Verma, Sourish Ghosh, Anirban Basu
Iscience|December 6, 2022
mRNA vaccines elicit potent neutralization against multiple SARS-CoV-2 omicron subvariants and other variants of concernGang Wang, Juan Shi, Abhishek K Verma, et al.
Iscience|October 12, 2023
Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challengeXiaoqing Guan, Abhishek K Verma, Gang Wang, et al.
Cells|December 10, 2025
MERS-CoV RBD-mRNA Presents Better Immunogenicity and Protection than the Spike-mRNAQian Liu, Abhishek K Verma, Xiaoqing Guan, et al.
Vaccines|June 27, 2024
A Unique mRNA Vaccine Elicits Protective Efficacy against the SARS-CoV-2 Omicron Variant and SARS-CoVXiaoqing Guan, Abhishek K Verma, Gang Wang, et al.
ACS Applied Bio Materials|May 23, 2025
Modulation of Doxorubicin-Induced ROS Accumulation in Cardiomyocytes Using Ibuprofen-Conjugated Synthetic Lipids as CarriersSoumya Saroj, Akshaya Kana Veedu, Chandrasekhar Reddy U, et al.
Pageof 2